<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="Association of past dengue fever epidemics with the risk of" exact="Zika" post="microcephaly at the population level in Brazil http://orcid.org/0000-0002-9566-0284CarvalhoMarilia Sámarilia.carvalho@fiocruz.br1http://orcid.org/0000-0001-9012-9382FreitasLaís"/>
 <result pre="http://creativecommons.org/licenses/by/4.0/. Abstract Despite all the research done on the first" exact="Zika" post="virus (ZIKV) epidemics, it was only after the Brazilian"/>
 <result pre="it was only after the Brazilian epidemic that the Congenital" exact="Zika" post="Syndrome was described. This was made possible due to"/>
 <result pre="is partially an effect of the population prior immunity against" exact="Dengue" post="viruses (DENV), that cross-react with ZIKV. In this ecological"/>
 <result pre="an effect of herd immunity and of multiple exposures to" exact="DENV" post="that could boost immunity. Subject terms Viral infection Epidemiology"/>
 <result pre="epidemic in the Northeast (NE) region of Brazil with the" exact="Zika" post="virus (ZIKV) was the high rate of dispersion of"/>
 <result pre="Despite all the research done on the first epidemics of" exact="ZIKV" post="in Yap Islands and later in French Polynesia2–4, it"/>
 <result pre="Polynesia2–4, it was only after the Brazilian epidemic that Congenital" exact="Zika" post="Syndrome (CZS) was described5. This could be due to"/>
 <result pre="any other region in the world that had undergone a" exact="Zika" post="epidemic7–9. Several reasons for this discrepancy were suggested –"/>
 <result pre="women postponing pregnancy or having abortions18–20. The antigenic similarity between" exact="ZIKV" post="and dengue virus (DENV), sharing approximately 54% of their"/>
 <result pre="have shown that anti-DENV antibodies can both enhance and neutralize" exact="ZIKV" post="infection22–26. In animal models, mice that received plasma with"/>
 <result pre="level of anti-DENV antibodies had a higher mortality rate after" exact="ZIKV" post="infection than mice that received plasma without antibodies. However,"/>
 <result pre="plasma with a high level of anti-DENV antibodies survived after" exact="ZIKV" post="challenge and presented milder symptoms22. Human plasma collected ≤100"/>
 <result pre="presented milder symptoms22. Human plasma collected ≤100 days after PCR-confirmed" exact="DENV" post="infection binds and cross-neutralizes ZIKV in vitro. On the"/>
 <result pre="collected ≤100 days after PCR-confirmed DENV infection binds and cross-neutralizes" exact="ZIKV" post="in vitro. On the other hand, late-convalescent-phase plasma does"/>
 <result pre="the understanding of cross-neutralizing antibody responses among individuals with prior" exact="DENV" post="exposure, particularly how these responses evolve over time and"/>
 <result pre="countries is quite unknown28. In summary, it is known that" exact="ZIKV" post="shares structural similarities with other flaviviruses, especially DENV, and"/>
 <result pre="with other flaviviruses, especially DENV, and co-circulates in dengue-endemic regions." exact="ZIKV" post="and DENV cross-immunity can be either protective or enhancing"/>
 <result pre="flaviviruses, especially DENV, and co-circulates in dengue-endemic regions. ZIKV and" exact="DENV" post="cross-immunity can be either protective or enhancing in experimental"/>
 <result pre="2014 data, both in the exploratory analysis and the maps." exact="Dengue" post="data are collected by the Brazilian Information System for"/>
 <result pre="cases decreased first in the NE, the dispersion centre of" exact="Zika" post="epidemic, followed by the SE and CW regions. Table"/>
 <result pre="of microcephaly rate among live-born neonates in 2014, before the" exact="Zika" post="epidemic. Among the 400 microregions included in the analysis,"/>
 <result pre="described. It should be noted that the notification system for" exact="Zika" post="was only implemented in February 2016, when the Zika"/>
 <result pre="for Zika was only implemented in February 2016, when the" exact="Zika" post="epidemic was decreasing in the NE region. Therefore, we"/>
 <result pre="in the NE region. Therefore, we could not control for" exact="Zika" post="incidence in the models. It is possible that the"/>
 <result pre="the differences in microcephaly rates were a consequence of different" exact="ZIKV" post="attack rates across the regions, as suggested in a"/>
 <result pre="paper37. In this study, after testing for other concurrent factors," exact="ZIKV" post="was assumed to be the only cause of the"/>
 <result pre="epidemic, with no unmeasured confounders or effect modifiers. However, if" exact="Zika" post="incidence alone explains the excess microcephaly rates, then microcephaly"/>
 <result pre="to why the NE region would have presented with a" exact="Zika" post="incidence more than ten times larger than anywhere else"/>
 <result pre="interval between infections changes the role of anti-DENV antibodies on" exact="ZIKV" post="infection, either to protect or to increase the risk"/>
 <result pre="hypothesis is based on what is described for sequential heterotypic" exact="DENV" post="infections (there are four DENV serotypes). It has been"/>
 <result pre="is described for sequential heterotypic DENV infections (there are four" exact="DENV" post="serotypes). It has been established that a narrow range"/>
 <result pre="over time, there is a window of cross-protection between the" exact="DENV" post="serotypes. A previous study found that a shorter interval"/>
 <result pre="seems to play a role against ZIKV. Mice primed with" exact="DENV" post="and 30 days later challenged with ZIKV during pregnancy"/>
 <result pre="Mice primed with DENV and 30 days later challenged with" exact="ZIKV" post="during pregnancy presented reduced burden in maternal and fetal"/>
 <result pre="required for this cross-protection. However, mice challenged 80 days after" exact="DENV" post="priming were not protected, indicating the transient nature of"/>
 <result pre="of cross-protection again40. Figure 7 Hypothesized interaction between dengue and" exact="Zika" post="infections on the development of microcephaly. Most research on"/>
 <result pre="of previous DENV-immunity on the severity of clinical symptoms of" exact="ZIKV" post="infection is based on experimental models41,42. Cohort studies are"/>
 <result pre="give the most reliable understanding of the role of previous" exact="DENV" post="exposure on ZIKV infection. However, the reduction in the"/>
 <result pre="reliable understanding of the role of previous DENV exposure on" exact="ZIKV" post="infection. However, the reduction in the incidence of Zika"/>
 <result pre="on ZIKV infection. However, the reduction in the incidence of" exact="Zika" post="after the last epidemic in Brazil in 2016 limits"/>
 <result pre="study dengue and that have been adapted to also study" exact="Zika" post="are of great value. For example, a recent study"/>
 <result pre="Brazil, found that the titres of DENV-antibodies measured before the" exact="Zika" post="epidemic were inversely associated with the risk of ZIKV"/>
 <result pre="the Zika epidemic were inversely associated with the risk of" exact="ZIKV" post="infection46. In a paediatric cohort in Nicaragua, prior DENV"/>
 <result pre="of ZIKV infection46. In a paediatric cohort in Nicaragua, prior" exact="DENV" post="infection was inversely associated with the risk of symptomatic"/>
 <result pre="DENV infection was inversely associated with the risk of symptomatic" exact="ZIKV" post="infection47. In a cohort of ZIKV-infected pregnant women, previous"/>
 <result pre="ZIKV infection47. In a cohort of ZIKV-infected pregnant women, previous" exact="DENV" post="infection was not associated with disease severity and abnormal"/>
 <result pre="human immune sera, which showed a cross-neutralizing antibody response to" exact="ZIKV" post="on DENV-immune subjects 1–3 years after DENV infection28. The"/>
 <result pre="antibody response to ZIKV on DENV-immune subjects 1–3 years after" exact="DENV" post="infection28. The larger window at the ecological level is"/>
 <result pre="an effect of herd immunity and of multiple exposures to" exact="DENV" post="that would boost immunity. This is consistent with a"/>
 <result pre="This is consistent with a case-control study in which the" exact="DENV" post="seroprevalence and the mean number of neutralized serotypes (indicative"/>
 <result pre="led to the early discovery of the causal link between" exact="Zika" post="and microcephaly may have generated a hyper-awareness of the"/>
 <result pre="surveillance system for neonatal malformation clustered in space and time." exact="Dengue" post="epidemics in the previous 15 years were used as"/>
 <result pre="published since 2002. Other possible factors in the pathway between" exact="Zika" post="infection and microcephaly have been suggested, the most important"/>
 <result pre="limitations of this study, in addition to not controlling for" exact="Zika" post="incidence, are well known: accuracy of microcephaly classification and"/>
 <result pre="our results. The detection of either ADE or cross-protection between" exact="DENV" post="and ZIKV is not a trivial task, either in"/>
 <result pre="The detection of either ADE or cross-protection between DENV and" exact="ZIKV" post="is not a trivial task, either in animal models"/>
 <result pre="contribute to building the knowledge regarding the relationship between DENV," exact="ZIKV" post="and congenital Zika syndrome. Supplementary information LINK Supplementary information"/>
 <result pre="the knowledge regarding the relationship between DENV, ZIKV and congenital" exact="Zika" post="syndrome. Supplementary information LINK Supplementary information Publisher’s note Springer"/>
 <result pre="The authors declare no competing interests. References References 1.LoweRet al.The" exact="Zika" post="Virus Epidemic in Brazil: From Discovery to Future ImplicationsInt."/>
 <result pre="in French PolynesiaLancet20163871051105210.1016/S0140-6736(16)00625-5 5.Miranda-FilhoDEBet al.Initial Description of the Presumed Congenital" exact="Zika" post="SyndromeAm. J. Public. Health201610659860010.2105/AJPH.2016.30311526959258 6.de OliveiraWKet al.Infection-related microcephaly after"/>
 <result pre="Health201610659860010.2105/AJPH.2016.30311526959258 6.de OliveiraWKet al.Infection-related microcephaly after the 2015 and 2016" exact="Zika" post="virus outbreaks in Brazil: a surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 7.CoelhoACrovellaSMicrocephaly Prevalence"/>
 <result pre="Brazil: a surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 7.CoelhoACrovellaSMicrocephaly Prevalence in Infants Born to" exact="Zika" post="Virus-Infected Women: A Systematic Review and Meta-AnalysisInt. J. Mol."/>
 <result pre="in Rio de JaneiroN. Engl. J. Med.20163752321233410.1056/NEJMoa160241226943629 9.VogelGOne year later," exact="Zika" post="scientists prepare for a long warSci.20163541088108910.1126/science.354.6316.1088 10.Albuquerque, M. de"/>
 <result pre="Microcephaly at Birth in Brazil in 2010Pediatrics2018141e2017058910.1542/peds.2017-058929305391 12.RodriguesLaura CMicrocephaly and" exact="Zika" post="virus infectionThe Lancet2016387100332070207210.1016/S0140-6736(16)00742-X 13.ButlerDMicrocephaly surge in doubtNat.2016530131410.1038/nature.2016.19259 14.Lopez-Camelo, J."/>
 <result pre="I. M. &amp;amp; Castilla, E. ECLAMC FINAL DOCUMENT (2015). 15.RossiSLEbelGDShanCShiP-YVasilakisNDid" exact="Zika" post="Virus Mutate to Cause Severe Outbreaks?Trends Microbiology20182687788510.1016/j.tim.2018.05.007 16.Souza, W."/>
 <result pre="W. V. de et al. Microcephaly epidemic related to the" exact="Zika" post="virus and living conditions in Recife, Northeast Brazil. BMC"/>
 <result pre="Northeast Brazil. BMC Public Health18 (2018). 17.HalsteadSBBiologic Evidence Required for" exact="Zika" post="Disease Enhancement by Dengue AntibodiesEmerg. Infect. Dis.20172356957310.3201/eid2304.16187928322690 18.AikenARAet al.Requests"/>
 <result pre="Health18 (2018). 17.HalsteadSBBiologic Evidence Required for Zika Disease Enhancement by" exact="Dengue" post="AntibodiesEmerg. Infect. Dis.20172356957310.3201/eid2304.16187928322690 18.AikenARAet al.Requests for Abortion in Latin"/>
 <result pre="al.Requests for Abortion in Latin America in the Wake of" exact="Zika" post="VirusN. Engl. J. Med.201637539639810.1056/NEJMc160538927331661 19.Diaz-QuijanoFAPelissariDMChiavegatto FilhoADPZika-Associated Microcephaly Epidemic and"/>
 <result pre="Rate Reduction in Brazilian CitiesAm. J. Public. Health201810851451610.2105/AJPH.2017.30426029470110 20.CastroMCHanQCCarvalhoLRVictoraCGFrançaGVAImplications of" exact="Zika" post="virus and congenital Zika syndrome for the number of"/>
 <result pre="CitiesAm. J. Public. Health201810851451610.2105/AJPH.2017.30426029470110 20.CastroMCHanQCCarvalhoLRVictoraCGFrançaGVAImplications of Zika virus and congenital" exact="Zika" post="syndrome for the number of live births in BrazilProc."/>
 <result pre="antibody responses after dengue virus infection are highly cross-reactive to" exact="Zika" post="virusProc. Natl Acad. Sci. USA20161137852785710.1073/pnas.160793111327354515 22.BardinaSVet al.Enhancement of Zika"/>
 <result pre="to Zika virusProc. Natl Acad. Sci. USA20161137852785710.1073/pnas.160793111327354515 22.BardinaSVet al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunitySci.201735617518010.1126/science.aal4365 23.DurbinAPDengue Antibody and"/>
 <result pre="Sequence in MiceImmun.20174677177310.1016/j.immuni.2017.04.023 25.RobbianiDFet al.Recurrent Potent Human Neutralizing Antibodies to" exact="Zika" post="Virus in Brazil and MexicoCell2017169597609.e1110.1016/j.cell.2017.04.02428475892 26.WenJShrestaSADE-ing and Abetting ZikaCell"/>
 <result pre="ZikaCell Host Microbe20172155755810.1016/j.chom.2017.04.00628494235 27.CollinsMHet al.Lack of Durable Cross-Neutralizing Antibodies Against" exact="Zika" post="Virus from Dengue Virus InfectionEmerg. Infect. Dis.20172377378110.3201/eid2305.16163028418292 28.MontoyaMageldaCollinsMatthewDejnirattisaiWanwisaKatzelnickLeah CPuerta-GuardoHenryJadiRameshSchildhauerSamuelSupasaPiyadaVasanawathanaSirijittMalasitPridaMongkolsapayaJuthathipde"/>
 <result pre="27.CollinsMHet al.Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from" exact="Dengue" post="Virus InfectionEmerg. Infect. Dis.20172377378110.3201/eid2305.16163028418292 28.MontoyaMageldaCollinsMatthewDejnirattisaiWanwisaKatzelnickLeah CPuerta-GuardoHenryJadiRameshSchildhauerSamuelSupasaPiyadaVasanawathanaSirijittMalasitPridaMongkolsapayaJuthathipde SilvaAruna DTisseraHasithaBalmasedaAngelScreatonGavinde SilvaAravinda"/>
 <result pre="CPuerta-GuardoHenryJadiRameshSchildhauerSamuelSupasaPiyadaVasanawathanaSirijittMalasitPridaMongkolsapayaJuthathipde SilvaAruna DTisseraHasithaBalmasedaAngelScreatonGavinde SilvaAravinda MHarrisEvaLongitudinal Analysis of Antibody Cross-neutralization Following" exact="Zika" post="Virus and Dengue Virus Infection in Asia and the"/>
 <result pre="SilvaAravinda MHarrisEvaLongitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and" exact="Dengue" post="Virus Infection in Asia and the AmericasThe Journal of"/>
 <result pre="30.AndradeDaniela V.HarrisEvaRecent advances in understanding the adaptive immune response to" exact="Zika" post="virus and the effect of previous flavivirus exposureVirus Research2018254273310.1016/j.virusres.2017.06.01928655548"/>
 <result pre="‘Tidyverse’ (2017). 36.The R-INLA project http://www.r-inla.org/home. 37.BradyOJet al.The association between" exact="Zika" post="virus infection and microcephaly in Brazil 2015–2017: An observational"/>
 <result pre="Med.197042311328 39.AndersonKBet al.A Shorter Time Interval Between First and Second" exact="Dengue" post="Infections Is Associated With Protection From Clinical Illness in"/>
 <result pre="in ThailandJ. Infect. Dis.201420936036810.1093/infdis/jit43623964110 40.Regla-Nava, J. A. et al. Cross-reactive" exact="Dengue" post="virus-specific CD8+ T cells protect against Zika virus during"/>
 <result pre="et al. Cross-reactive Dengue virus-specific CD8+ T cells protect against" exact="Zika" post="virus during pregnancy. Nature Communications9 (2018). 41.Martín-Acebes, M. A.,"/>
 <result pre="by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in" exact="Zika" post="Virus Infection. Front Immunol9 (2018). 43.CohenJWhere has all the"/>
 <result pre="Zika Virus Infection. Front Immunol9 (2018). 43.CohenJWhere has all the" exact="Zika" post="gone?Sci.201735763163210.1126/science.357.6352.631 44.SiednerMJRyanETBogochIIGone or forgotten? The rise and fall of"/>
 <result pre="Zika gone?Sci.201735763163210.1126/science.357.6352.631 44.SiednerMJRyanETBogochIIGone or forgotten? The rise and fall of" exact="Zika" post="virusLancet Public. Health20183e109e11010.1016/S2468-2667(18)30029-X29519697 45.Netto, E. M. et al. High"/>
 <result pre="Zika virusLancet Public. Health20183e109e11010.1016/S2468-2667(18)30029-X29519697 45.Netto, E. M. et al. High" exact="Zika" post="Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential"/>
 <result pre="46.Rodriguez-Barraquer, I. et al. Impact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic region. 5 (2019)."/>
 <result pre="of Zika: A pediatric cohort in NicaraguaPLOS Med.201916e100272610.1371/journal.pmed.100272630668565 48.HalaiU-Aet al.Maternal" exact="Zika" post="Virus Disease Severity, Virus Load, Prior Dengue Antibodies, and"/>
 <result pre="Med.201916e100272610.1371/journal.pmed.100272630668565 48.HalaiU-Aet al.Maternal Zika Virus Disease Severity, Virus Load, Prior" exact="Dengue" post="Antibodies, and Their Relationship to Birth OutcomesClin. Infect. Dis.20176587788310.1093/cid/cix47228535184"/>
 <result pre="to Birth OutcomesClin. Infect. Dis.20176587788310.1093/cid/cix47228535184 49.PedrosoCeliaFischerCarloFeldmannMarieSarnoManoelLuzEstelaMoreira-SotoAndrésCabralRenataNettoEduardo MartinsBritesCarlosKümmererBeate M.DrexlerJan FelixCross-Protection of" exact="Dengue" post="Virus Infection against Congenital Zika Syndrome, Northeastern BrazilEmerging Infectious"/>
 <result pre="49.PedrosoCeliaFischerCarloFeldmannMarieSarnoManoelLuzEstelaMoreira-SotoAndrésCabralRenataNettoEduardo MartinsBritesCarlosKümmererBeate M.DrexlerJan FelixCross-Protection of Dengue Virus Infection against Congenital" exact="Zika" post="Syndrome, Northeastern BrazilEmerging Infectious Diseases20192581485149310.3201/eid2508.19011331075077 50.VictoraCGet al.Microcephaly in Brazil:"/>
</results>
